NASDAQ$SERA
Sera Prognostics Inc-A · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Reported fourth quarter and full year 2023 financial results.
Sera Prognostics reported fourth quarter 2023 revenue of $41,000, a decrease compared to $65,000 for the same period in 2022. The net loss for the quarter was $7.9 million, compared to $9.7 million for the same quarter a year ago.
- DSMB recommended stopping enrollment in the PRIME study due to efficacy.
- Preparing manuscript submission to premier medical publications for the PRIME study.
- Making progress in development of product pipeline and PreTRM® sample collection and assay enhancements.
- Engaged in focused commercial activities ahead of PRIME data to build toward greater PreTRM® test adoption expectations in 2024-2025.
Headline financials
Revenue & EPS history
Sera Prognostics · Revenue · Quarterly
$41K
Forward guidance
Sera is looking forward to an exciting year of developments, including publication of their PRIME study results while executing on commercial expansion and plans to establish direct relationships with expectant mothers, expecting these activities and advancements in their product pipeline to complement what they believe is their leading position in the area of maternal and neonatal health and pave the way for a future inflection in revenue growth.
Tailwinds
- Publication of PRIME study results in 2024.
- Commercial expansion.
- Plans to establish direct relationships with expectant mothers.
- Advancements in product pipeline.
- Potential future inflection in revenue growth.
Headwinds
- Net losses.
- Need to generate cash.
- Potential need to raise more capital.
- Revenues from the PreTRM Test representing substantially all Company revenues to date.
- The need for broad scientific and market acceptance of the PreTRM Test.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
-1.9%
Avg return
Earnings day
-3.5%
Avg return
5 days after
-3.3%
Avg return
30 days after
36%
8 / 22 earnings
Positive
+14.3%
Q3 2022
Best reaction
-11.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.7% | -8.0% | +18.1% | |
| Q4 2025 | -7.7% | +6.3% | +20.4% | |
| Q3 2025 | +1.7% | +8.5% | +19.0% | |
| Q1 2025 | -11.7% | -2.1% | -35.4% | |
| Q4 2024 | -5.1% | -2.2% | -17.9% | |
| Q3 2024 | -0.3% | -2.7% | -3.9% | |
| Q2 2024 | +0.0% | -1.2% | -2.2% | |
| Q1 2024 | +3.3% | -4.0% | -13.6% | |
| Q4 2023 | +3.4% | +1.1% | +7.7% | |
| Q3 2023 | -3.2% | -6.4% | +130.9% | |
| Q2 2023 | +0.8% | -10.1% | -39.9% | |
| Q1 2023 | -0.8% | -2.8% | -13.0% | |
| Q4 2022 | -10.0% | -9.5% | -22.3% | |
| Q3 2022 | +14.3% | +11.1% | -4.0% | |
| Q2 2022 | -4.1% | -6.3% | -27.3% | |
| Q1 2022 | -7.6% | -17.1% | -32.7% | |
| Q4 2021 | +3.6% | +0.3% | -39.3% | |
| Q3 2021 | +0.3% | -0.8% | -8.2% | |
| Q3 2020 | +0.3% | -0.8% | -8.2% | |
| Q2 2021 | -4.8% | -9.9% | +0.0% | |
| Q1 2021 | -4.8% | -9.9% | +0.0% | |
| Q4 2020 | -4.8% | -9.9% | +0.0% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro